XP-5

Patents

One entry per invention. Patent families filed in the US, EP, WO and CN offices.

Biologically active methylene blue derivatives
US 7915254 B2Applicant: PHOTOPHARMICA LTDPriority: 2008
US
4 publications
MANNITOL AND/OR PROLINE FOR PREVENTION AND TREATMENT OF AGEING RELATED SYMPTOMS
US 2009247476 A1Applicant: ERASMUS MCPriority: 2006
US
2 publications
Process for producing organotitanium compound and process for addition reaction
US 2003096996 A1Applicant: SATO FUMIEPriority: 2001
US
Fragments of proinsulin c-peptide
US 2006234914 A1Applicant: CREATIVE PEPTIDES SWEDEN ABPriority: 2002
US
Novel cysteine-depleted hydrophobin fusion proteins, their production and use thereof
US 2009136996 A1Applicant: BASF AGPriority: 2005
US
Use of Hydrophobin-Polypeptides and Conjugates From Hydrophobin-Polypeptides Having Active and Effect Agents and the Production Thereof and Use Thereof In the Cosmetic Industry
US 2009136433 A1Applicant: BASF AGPriority: 2005
US
METHOD OF COVALENTLY LINKING A CARBOHYDRATE OR POLYALKYLENE OXIDE TO A PEPTIDE, PRECURSORS FOR USE IN THE METHOD AND RESULTANT PRODUCTS
US 2010069607 A1Applicant: UCL BUSINESS PLCPriority: 2006
US
Preparation method of probiotic antibacterial gel
CN 110404010 AApplicant: GUIZHOU WARMAN TECH CO LTDPriority: 2019
CN
Exosome secreted by liver tumor cells with high MHC-I expression and targeting liver potential and preparation method thereof
CN 111979268 AApplicant: SHANGHAI 10TH PEOPLES HOSPITALPriority: 2020
CN
Method for extracting quercetin by utilizing phomopsis XP-8
CN 118164944 AApplicant: UNIV NORTHWESTERN POLYTECHNICALPriority: 2024
CN